Joel Davidson, 79, prostate cancer, Naples, FL, with Mark Pomerantz, MD, Clinical Director for the Lank Center for Genitourinary Oncology, Dana-Farber

WEEI/NESN Jimmy Fund Radio-Telethon

Nine years ago, Joel was diagnosed with prostate cancer at his annual wellness exam while living in Connecticut; his best friend was his urologist at the time. He began making regular visits to Boston to get treated at Dana-Farber.

Dr. Mark Pomerantz is a medical oncologist and Clinical Director for the Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute. Dr. Pomerantz received his undergraduate degree from Yale University and his medical degree from Stanford University. He trained in Internal Medicine at Brigham and Women's Hospital in Boston, Massachusetts. He then pursued a fellowship in Medical Oncology at Dana-Farber. Dr. Pomerantz received his post-doctoral training in cancer genetics with Dr. Matthew Freedman at Dana-Farber and the Broad Institute of Harvard and MIT. He also teaches as an Assistant Professor of Medicine at Harvard Medical School.